德克斯公司的股票在FDA警告其工厂的制造和质量问题后下跌. DexCom's stock drops after FDA warning over manufacturing and quality issues at its facilities.

DexCom是一家医疗装置公司,在收到林业发展局的警告信后,其股票价值下降。 DexCom, a medical device company, saw its stock value decline after receiving a warning letter from the FDA. 这封信是在对DexCom在圣地亚哥和梅萨的设施进行视察之后发出的,视察查明了对该公司制造流程和质量管理系统的关切。 The letter followed inspections at DexCom's facilities in San Diego and Mesa, which identified concerns regarding the company's manufacturing processes and quality management systems. 美国食品和药物管理局强调需要解决这些问题,以确保产品的安全性和监管合规性. The FDA emphasized the need to address these issues to ensure product safety and regulatory compliance.